无其他呼吸道疾病情况下的嗅觉丧失和味觉障碍：是否应考虑新冠病毒感染？
Anosmia and Dysgeusia in the Absence of Other Respiratory Diseases: Should COVID-19 Infection Be Considered?
作者信息
Lorenzo Villalba Noel, Maouche Yasmine, Alonso Ortiz Maria Belen, Cordoba Sosa Zaida, Chahbazian Jean Baptiste, Syrovatkova Aneska, Pertoldi Pierre, Andres Emmanuel, Zulfiqar Abrar-Ahmad
机构信息
Service de Médecine Interne, Diabète et Maladies Métaboliques, Hôpitaux Universitaires de Strasbourg, France.
Internal Medicine Department, Dr Negrin University Hospital, Gran Canaria, Spain.
出版信息
Eur J Case Rep Intern Med. 2020 Apr 3;7(4):001641. doi: 10.12890/2020_001641. eCollection 2020.
Abstract
UNLABELLED
We describe two elderly patients evaluated at emergency departments for anosmia/dysgeusia in the absence of any other respiratory symptoms prior to or upon admission. In the current epidemiological context, clinical and biological work-up led to a diagnosis of COVID-19 infection. Unfortunately, one of the patients died during hospitalization, but the other recovered and was discharged.
LEARNING POINTS
In the current epidemiological situation, anosmia and dysgeusia in the absence of other respiratory conditions should be carefully evaluated.Special attention should be given to patients with non-classic COVID-19 symptoms in order to reduce transmission and protect health providers.
摘要
未标注
我们描述了两名老年患者，他们在急诊科接受评估，入院前或入院时存在嗅觉减退/味觉障碍，且无任何其他呼吸道症状。在当前的流行病学背景下，临床和生物学检查导致确诊为新冠病毒感染。不幸的是，其中一名患者在住院期间死亡，但另一名患者康复并出院。
学习要点
在当前的流行病学形势下，应仔细评估无其他呼吸道疾病的嗅觉减退和味觉障碍。应特别关注有非典型新冠病毒症状的患者，以减少传播并保护医护人员。
相似文献
1
Anosmia and Dysgeusia in the Absence of Other Respiratory Diseases: Should COVID-19 Infection Be Considered?无其他呼吸道疾病情况下的嗅觉丧失和味觉障碍：是否应考虑新冠病毒感染？
Eur J Case Rep Intern Med. 2020 Apr 3;7(4):001641. doi: 10.12890/2020_001641. eCollection 2020.
2
COVID-19 with and without anosmia or dysgeusia: A case-control study.伴有或不伴有嗅觉丧失或味觉障碍的 COVID-19：一项病例对照研究。
J Med Virol. 2021 Apr;93(4):2499-2504. doi: 10.1002/jmv.26784. Epub 2021 Jan 22.
3
A comparative study on the clinical features of COVID-19 with non-SARS-CoV-2 respiratory viral infections.新型冠状病毒与非 SARS-CoV-2 呼吸道病毒感染的临床特征比较研究。
J Med Virol. 2021 Mar;93(3):1548-1555. doi: 10.1002/jmv.26486. Epub 2020 Sep 29.
4
Epidemiological Chronicle of the First Recovered Coronavirus Disease Patient From Panama: Evidence of Early Cluster Transmission in a High School of Panama City.巴拿马首例新冠康复患者的流行病学纪事：巴拿马城一所高中早期聚集性传播的证据
Front Public Health. 2020 Sep 15;8:553730. doi: 10.3389/fpubh.2020.553730. eCollection 2020.
5
Risk Factors for Olfactory and Gustatory Dysfunctions in Patients with SARS-CoV-2 Infection.SARS-CoV-2 感染患者嗅觉和味觉功能障碍的危险因素。
Neuroepidemiology. 2021;55(2):154-161. doi: 10.1159/000514888. Epub 2021 Apr 1.
6
COVID-19 Anosmia Reporting Tool: Initial Findings.COVID-19 嗅觉丧失报告工具：初步研究结果。
Otolaryngol Head Neck Surg. 2020 Jul;163(1):132-134. doi: 10.1177/0194599820922992. Epub 2020 Apr 28.
7
Does COVID-19 cause permanent damage to olfactory and gustatory function?新冠病毒会对嗅觉和味觉功能造成永久性损害吗？
Med Hypotheses. 2020 Oct;143:110086. doi: 10.1016/j.mehy.2020.110086. Epub 2020 Jul 9.
8
Attributes of dysgeusia and anosmia of coronavirus disease 2019 (COVID-19) in hospitalized patients.COVID-19 住院患者味觉障碍和嗅觉障碍的特征。
Oral Dis. 2022 Apr;28 Suppl 1:891-898. doi: 10.1111/odi.13713. Epub 2020 Nov 28.
9
Stellate Ganglion Block for Anosmia and Dysgeusia Due to Long COVID.星状神经节阻滞治疗新冠后嗅觉丧失和味觉障碍
Cureus. 2022 Aug 8;14(8):e27779. doi: 10.7759/cureus.27779. eCollection 2022 Aug.
10
Respiratory Distress in SARS-CoV-2 without Lung Damage: Phrenic Paralysis Should Be Considered in COVID-19 Infection.新型冠状病毒2型感染无肺损伤时的呼吸窘迫：2019冠状病毒病感染应考虑膈神经麻痹
Eur J Case Rep Intern Med. 2020 May 21;7(6):001728. doi: 10.12890/2020_001728. eCollection 2020.
引用本文的文献
1
Are olfactory and gustatory symptoms useful at predicting disease severity markers in COVID-19 infection?嗅觉和味觉症状对预测新冠病毒感染中的疾病严重程度指标是否有用？
Natl J Maxillofac Surg. 2022 Sep-Dec;13(3):357-361. doi: 10.4103/njms.njms_38_22. Epub 2022 Dec 10.
2
COVID-19 loss of taste and smell: potential psychological repercussions.新冠病毒引起的味觉和嗅觉丧失：潜在的心理影响。
Pan Afr Med J. 2022 Sep 21;43:38. doi: 10.11604/pamj.2022.43.38.31329. eCollection 2022.
3
The efficacy and safety of acupuncture in the treatment of taste disorders after rehabilitation from COVID-19: A protocol for systematic review and meta-analysis.针灸治疗 COVID-19 康复后味觉障碍的疗效和安全性：系统评价和荟萃分析方案。
Medicine (Baltimore). 2022 Nov 25;101(47):e31649. doi: 10.1097/MD.0000000000031649.
4
Molecular mechanisms involved in anosmia induced by SARS-CoV-2, with a focus on the transmembrane serine protease TMPRSS2.SARS-CoV-2 引起嗅觉丧失的分子机制，重点关注跨膜丝氨酸蛋白酶 TMPRSS2。
Arch Virol. 2022 Oct;167(10):1931-1946. doi: 10.1007/s00705-022-05545-0. Epub 2022 Aug 8.
5
Asthma and Cacosmia Could Be Predictive Factors of Olfactory Dysfunction Persistence 9 Months after SARS-CoV-2 Infection: The ANOSVID Study.哮喘和嗅觉倒错可能是新冠病毒感染9个月后嗅觉功能障碍持续存在的预测因素：ANOSVID研究。
Life (Basel). 2022 Jun 21;12(7):929. doi: 10.3390/life12070929.
6
Seroprevalence of anti-SARS-CoV-2 IgG antibodies: relationship with COVID-19 diagnosis, symptoms, smoking, and method of transmission.抗SARS-CoV-2 IgG抗体的血清流行率：与COVID-19诊断、症状、吸烟及传播方式的关系。
IJID Reg. 2022 Sep;4:10-16. doi: 10.1016/j.ijregi.2022.05.007. Epub 2022 May 27.
7
Investigating training-test data splitting strategies for automated segmentation and scoring of COVID-19 lung ultrasound images.研究用于 COVID-19 肺部超声图像自动分割和评分的训练-测试数据分割策略。
J Acoust Soc Am. 2021 Dec;150(6):4118. doi: 10.1121/10.0007272.
8
The Role of ACE2 Receptors of the Olfactory System in Anosmia in COVID-19: An Overview.嗅觉系统的血管紧张素转换酶2（ACE2）受体在新型冠状病毒肺炎嗅觉丧失中的作用：综述
Neurol Res Int. 2021 Aug 31;2021:5776801. doi: 10.1155/2021/5776801. eCollection 2021.
9
Predictive usefulness of RT-PCR testing in different patterns of Covid-19 symptomatology: analysis of a French cohort of 12,810 outpatients.实时聚合酶链反应（RT-PCR）检测在不同 COVID-19 症状模式中的预测价值：对法国 12810 名门诊患者队列的分析。
Sci Rep. 2021 Oct 27;11(1):21233. doi: 10.1038/s41598-021-99991-6.
10
Olfactory dysfunction in the scenario of COVID-19 pandemic in patients screened by the telemonitoring.通过远程监测筛查的COVID-19大流行情况下患者的嗅觉功能障碍
Einstein (Sao Paulo). 2021 Oct 11;19:eAO6204. doi: 10.31744/einstein_journal/2021AO6204. eCollection 2021.
本文引用的文献
1
Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study.严重急性呼吸综合征冠状病毒2感染患者的自我报告嗅觉和味觉障碍：一项横断面研究。
Clin Infect Dis. 2020 Jul 28;71(15):889-890. doi: 10.1093/cid/ciaa330.
2
Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms.74 例伴有胃肠道症状的 2019 年冠状病毒病（COVID-19）患者的流行病学、临床和病毒学特征。
Gut. 2020 Jun;69(6):1002-1009. doi: 10.1136/gutjnl-2020-320926. Epub 2020 Mar 24.
3
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
4
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
Zotero 插件